Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Neurotherapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102690252B details a novel Stiripentol synthesis route converting synthesis by-products into high-value epilepsy intermediates, offering significant cost and supply chain advantages.
Patent CN106957307A reveals a novel dantrolene sodium derivative synthesis offering improved blood-brain barrier permeability and substantial supply chain cost advantages.